A detailed history of Rock Point Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Rock Point Advisors, LLC holds 7,100 shares of NVO stock, worth $745,926. This represents 0.24% of its overall portfolio holdings.

Number of Shares
7,100
Previous 7,100 -0.0%
Holding current value
$745,926
Previous $1.01 Million 16.58%
% of portfolio
0.24%
Previous 0.31%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $30,633 - $40,775
-300 Reduced 4.05%
7,100 $911,000
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $336,478 - $738,298
3,700 Added 100.0%
7,400 $672,000
Q1 2023

May 10, 2023

SELL
$132.34 - $159.14 $13,234 - $15,913
-100 Reduced 2.63%
3,700 $589,000
Q1 2021

May 12, 2021

SELL
$67.06 - $75.82 $13,412 - $15,163
-200 Reduced 5.0%
3,800 $256,000
Q1 2020

May 07, 2020

SELL
$49.46 - $64.78 $24,730 - $32,390
-500 Reduced 11.11%
4,000 $241,000
Q4 2019

Feb 06, 2020

BUY
$49.86 - $58.26 $224,370 - $262,170
4,500 New
4,500 $260,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Rock Point Advisors, LLC Portfolio

Follow Rock Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rock Point Advisors, LLC with notifications on news.